Research progress of oxidative stress increasing the risk of cardiovascular disease of polycystic ovary syndrome patients

doi:10.16352/j.issn.1001-6325.2022.12.1950

Abstract

Abstract: Polycystic ovary syndrome (PCOS) is related to obesity, hyperinsulinemia, impaired glucose toler-ance, hyperandrogenism, chronic inflammatory response, dyslipidemia and hypertension. PCOS is critically associated with oxidative stress (OS), which is a risk factor for cardiovascular disease (CVD). This article reviews the mechanisms by which OS increases the risk of CVD in PCOS and the possibility of preventing CVD in PCOS patients by blocking the pathway of reactive oxygen species (ROS) production.

Key words: polycystic ovary syndrome, oxidative stress, endothelial dysfunction, atherosclerosis

CLC Number:

R588.6

LI Huan-huan, ZHANG Yu-qi, LYU Hai-hong. Research progress of oxidative stress increasing the risk of cardiovascular disease of polycystic ovary syndrome patients[J]. Basic & Clinical Medicine, 2022, 42(12): 1950-1954.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2022.12.1950

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2022/V42/I12/1950

References

[1]Skrzynska KJ, Zachurzok A, Gawlik AM. Metabolic and hormonal profile of adolescent girls with polycystic ovary syndrome with concomitant autoimmune thyroiditis[J]. Front Endocrinol, 2021, 12: 708910. doi: 10.3389/fendo.2021.708910.
[2]Joksimovic Jovic J, Sretenovic J, Jovic N, et al. Cardiovascular properties of the androgen-induced PCOS model in rats: the role of oxidative stress[J]. Oxid Med Cell Longev, 2021, 2021: 8862878. doi: 10.1155/2021/8862878.
[3]刘刚, 郭山岭, 胡永寸,等. 沉默VCAM-1基因降低ox-LDL诱导的HUVECs氧化损伤和凋亡[J].基础医学与临床,2019, 39: 1423-1426.
[4]Shukla P, Mukherjee S. Mitochondrial dysfunction: an emerging link in the pathophysiology of polycystic ovary syndrome[J]. Mitochondrion, 2020, 52: 24-39.
[5]Ansari MY, Ahmad N, Haqqi TM. Oxidative stress and inflammation in osteoarthritis pathogenesis: Role of polyphenols[J]. Biomed Pharmacother, 2020, 129: 110452. doi: 10.1016/j.biopha.2020.110452.
[6]Gong Y, Luo S, Fan P, et al. Growth hormone alleviates oxidative stress and improves oocyte quality in Chinese women with polycystic ovary syndrome: a randomized controlled trial[J]. Sci Rep, 2020, 10: 18769. doi: 10.1038/s41598-020-75107-4.
[7]Garcia-Sanchez A, Miranda-Diaz AG, Cardona-Munoz EG. The role of oxidative stress in physiopathology and pharmacological treatment with pro-and antioxidant properties in chronic diseases[J]. Oxid Med Cell Longev, 2020, 2020: 2082145. doi: 10.1155/2020/2082145.
[8]Bannigida DM, Nayak BS, Vijayaraghavan R. Insulin resistance and oxidative marker in women with PCOS[J]. Arch Physiol Biochem, 2020, 126: 183-186.
[9]Jamilian M, Mansury S, Bahmani F, et al. The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome[J]. J Ovarian Res, 2018, 11: 80. doi: 10.1186/s13048-018-0457-1.
[10]Artimani T, Karimi J, Mehdizadeh M, et al. Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS)[J]. Gynecol Endocrinol, 2018, 34: 148-152.
[11]Mizgier M, Jarzabek-Bielecka G, Wendland N, et al. Relation between inflammation, oxidative stress, and macronutrient intakes in normal and excessive body weight adolescent girls with clinical features of polycystic ovary syndrome[J]. Nutrients, 2021, 13:896. doi: 10.3390/nu13030896.
[12]Karamali M, Eghbalpour S, Rajabi S, et al. Effects of probiotic supplementation on hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial[J]. Arch Iran Med, 2018, 21: 1-7.
[13]Liu Y, Liu H, Li Z, et al. The release of peripheral immune inflammatory cytokines promote an inflammatory cascade in PCOS patients via altering the follicular microenvironment[J]. Front Immunol, 2021, 12: 685724. doi: 10.3389/fimmu.2021.685724.
[14]Liu Q, Xie YJ, Qu LH, et al. Dyslipidemia involvement in the development of polycystic ovary syndrome[J]. Taiwan J Obstet Gynecol, 2019, 58: 447-453.
[15]Nakayama A, Morita H, Kawahara T, et al. Association between testosterone and lipid profiles under statin therapy and its clinical impact on the cardiovascular event risk[J]. Heart Vessels, 2021. 36:1794-1803.
[16]Gonzalez F, Considine RV, Abdelhadi OA, et al. Oxidative stress in response to saturated fat ingestion is linked to insulin resistance and hyperandrogenism in polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 2019, 104: 5360-5371.
[17]Wang D, Wang T, Wang R, et al. Suppression of p66Shc prevents hyperandrogenism-induced ovarian oxidative stress and fibrosis[J]. J Transl Med, 2020, 18: 84. doi: 10.1186/s12967-020-02249-4.
[18]Forstermann U. Nitric oxide and oxidative stress in vascular disease[J]. Pflugers Arch, 2010, 459: 923-939.
[19]Adoga JO, Channa ML, Nadar A. Kolaviron attenuates cardiovascular injury in fructose-streptozotocin induced type-2 diabetic male rats by reducing oxidative stress, inflammation, and improving cardiovascular risk markers[J]. Biomed Pharmacother, 2021, 144: 112323. doi: 10.1016/j.biopha.2021.112323.
[20]Liao Y, Zhu E, Zhou W. Ox-LDL aggravates the oxidative stress and inflammatory responses of THP-1 macrophages by reducing the inhibition effect of miR-491-5p on MMP-9[J]. Front Cardiovasc Med, 2021, 8: 697236. doi: 10.3389/fcvm.2021.697236.
[21]Geng H, Wang A, Rong G, et al. The effects of ox-LDL in human atherosclerosis may be mediated in part via the toll-like receptor 4 pathway[J]. Mol Cell Biochem, 2010, 342: 201-206.
[22]王美惠, 毕徐堃, 傅国胜. 瑞舒伐他汀减轻脂多糖诱导的人晚期内皮祖细胞损伤[J].基础医学与临床,2019, 39: 769-775.
[23]Wassmann S, Laufs U, Baumer AT, et al. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species[J]. Hypertension, 2001, 37: 1450-1457.
[24]Izadi A, Ebrahimi S, Shirazi S, et al. Hormonal and metabolic effects of coenzyme Q10 and/or vitamin E in patients with polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 2019, 104: 319-327.
[25]Rahmani E, Samimi M, Ebrahimi FA, et al. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome[J]. Mol Cell Endocrinol, 2017, 439: 247-255.